| A comprehensive review of drug repurposing strategies against known drug targets of COVID-19 A Khataniar, U Pathak, S Rajkhowa, AN Jha Covid 2 (2), 148-167, 2022 | 47 | 2022 |
| Elucidating the interaction and stability of withanone and withaferin‐a with human serum albumin, lysozyme and hemoglobin using computational biophysical modeling S Rajkhowa, U Pathak, H Patgiri ChemistrySelect 7 (12), e202103938, 2022 | 5 | 2022 |
| Plasmodium falciparum: Experimental and theoretical approaches in last 20 years A Das, U Pathak, S Rajkhowa, AN Jha Current Topics and Emerging Issues in Malaria Elimination, 2021 | 4 | 2021 |
| ROCKs as a potential drug target to combat Alzheimer's disease F Ahmad, S Rankawat, U Pathak Protein Kinase Inhibitors, 409-433, 2022 | 2 | 2022 |
| Update on promising biomarkers for multiple sclerosis F Ahmad, U Pathak, A Das, A Dhar The Journal of Neurobehavioral Sciences 8 (1), 17-21, 2021 | 2 | 2021 |
| A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19. COVID. 2022; 2: 148–167 A Khataniar, U Pathak, S Rajkhowa, AN Jha s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Applications and Future U Pathak, A Das, PK Bora, S Rajkhowa Systems Biology, Bioinformatics and Livestock Science, 279, 2023 | | 2023 |
| Therapeutic Approach for COVID-19–Clinical Challenges and Implementation F Ahmad, A Das, S Suleman, U Pathak, S Naaz Revista Bionatura, 1404-1409, 2020 | | 2020 |
